Prosecution Insights
Prosecution Insights
8 pending office actions • 6 art units • 7 examiners • 0 of 8 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (12%) |
| §112 only | 2 (25%) |
| Double-patenting + other | 1 (12%) |
| Multi-statute (no §101) | 3 (38%) |
| No statute on record | 1 (12%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TINSLEY, BRENDAN THOMAS | 2 | 61.9% | +70.5% |
| ATALA, JAMIE JO | 1 | 48.0% | +36.8% |
| LARA, CAROLINE MONSERRAT | 1 | 100.0% | +0.0% |
| GRABER, JAMES J | 1 | 45.9% | +57.0% |
| MCANANY, JOHN D | 1 | 67.2% | +43.5% |
| XU, XIAOYUN | 1 | 59.9% | +31.9% |
| THUESON, HANNA MARIE | 1 | 77.3% | +26.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18696121 | METHOD FOR PRODUCING CELL HAVING DNA DELETION SPECIFIC TO ONE OF HOMOLOGOUS CHROMOSOMES | LARA, CAROLINE MONSERRAT | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18489722 | THERAPEUTIC AGENT FOR SOLID CANCERS, WHICH COMPRISES AXL INHIBITOR AS ACTIVE INGREDIENT | MCANANY, JOHN D | 22d |
| 18517402 | METHOD FOR PREPARING BROWN ADIPOCYTE | GRABER, JAMES J | 41d |
| 18008983 | EYE DISEASE EVALUATION METHOD | XU, XIAOYUN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17779567 | Method for Producing Brown Adipocytes | TINSLEY, BRENDAN THOMAS | 24d overdue |
| 18489722 | THERAPEUTIC AGENT FOR SOLID CANCERS, WHICH COMPRISES AXL INHIBITOR AS ACTIVE INGREDIENT | MCANANY, JOHN D | 22d |
| 18517402 | METHOD FOR PREPARING BROWN ADIPOCYTE | GRABER, JAMES J | 41d |
| 18853302 | CELL DETECTION DEVICE, CELL DIAGNOSIS SUPPORT DEVICE, CELL DETECTION METHOD, AND CELL DETECTION PROGRAM | ATALA, JAMIE JO | — |
| 18008983 | EYE DISEASE EVALUATION METHOD | XU, XIAOYUN | — |
| 17802824 | FUNCTIONAL HUMAN CORNEAL ENDOTHELIAL CELLS AND APPLICATION THEREOF | TINSLEY, BRENDAN THOMAS | — |
| 17779639 | Composition for Medium | THUESON, HANNA MARIE | — |
| Art Unit | Apps |
|---|---|
| 1634 | 2 |
| 1633 | 1 |
| 1631 | 1 |
| 1625 | 1 |
| 1797 | 1 |
| 1638 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18853302 | CELL DETECTION DEVICE, CELL DIAGNOSIS SUPPORT DEVICE, CELL DETECTION METHOD, AND CELL DETECTION PROGRAM | ATALA, JAMIE JO | — | — | Non-Final OA | — | Pending | Oct 01, 2024 |
| 18696121 | METHOD FOR PRODUCING CELL HAVING DNA DELETION SPECIFIC TO ONE OF HOMOLOGOUS CHROMOSOMES | LARA, CAROLINE MONSERRAT | 1633 | §102§103§112DP | Non-Final OA | — | Pending | Mar 27, 2024 |
| 18517402 | METHOD FOR PREPARING BROWN ADIPOCYTE | GRABER, JAMES J | 1631 | §103§112 | Non-Final OA | 41d | Pending | Nov 22, 2023 |
| 18489722 | THERAPEUTIC AGENT FOR SOLID CANCERS, WHICH COMPRISES AXL INHIBITOR AS ACTIVE INGREDIENT | MCANANY, JOHN D | 1625 | §102§103§112Other | Non-Final OA | 22d | Pending | Oct 18, 2023 |
| 18008983 | EYE DISEASE EVALUATION METHOD | XU, XIAOYUN | 1797 | §102§103 | Final Rejection | — | Pending | Dec 08, 2022 |
| 17802824 | FUNCTIONAL HUMAN CORNEAL ENDOTHELIAL CELLS AND APPLICATION THEREOF | TINSLEY, BRENDAN THOMAS | 1634 | §112 | Final Rejection | — | Pending | Aug 26, 2022 |
| 17779567 | Method for Producing Brown Adipocytes | TINSLEY, BRENDAN THOMAS | 1634 | §112 | Non-Final OA | 24d overdue | Pending | May 25, 2022 |
| 17779639 | Composition for Medium | THUESON, HANNA MARIE | 1638 | §103 | Final Rejection | — | Pending | May 25, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial